Promethera

MGI has been a cornerstone investor since our Series B round and provided beyond the financial backing the strategic and business development support, through its teams and in particular with Fuchikami-san, to effectively help us expand our business in Japan. Being visible in Japan today, a country leading the next generation stem cell revolution, is rewarding and a must for Promethera. John Tchelingerian, CEO

网站

基于肝细胞疗法的全球创新者为急性和慢性肝病患者提供治疗方案。

MGI帮助Promethera寻找扩大生产的合作机会,在日本的监管路径中导航,在企业中寻找商业发展机会以及介绍同行业中的影响力者。

渕上 欣司, 投资合伙人 我们提供 : 生物技术行业网络
生物技术专业
Autotalks

MGI has been a value-add investor since the early days of the company. Their supporting approach and in-depth insights about the Japanese market have helped tremendously throughout our penetration efforts in that market. They have proven to be a true partner in our long journey in the automotive market, always helping and providing valuable insight and advice. Hagai Zyss, CEO

网站

自动驾驶汽车之间的通信提前通知您.

MGI帮助AutoTalks与日本相关汽车公司取得业务往来,并通过其广泛的行业网络在日本引进战略投资者.

水野 敦之,投资总监 我们提供 : 业务知识
行业网络
goBalto

MGI has gone far and beyond the normal investor relationship - within the first quarter post investment they had set up 5 prospect meetings - they know what’s important to take businesses to the next level. Sujay Jadhav, CEO

网站

致力于帮助医药公司实现临床试验的管理高效率化

MGI在帮助goBalto打开日本制药公司和CRO公司的大门

清峰 正志,投资总监 我们提供 : 医疗健康IT领域的行业知识
渕上 欣司,投资合伙人 我们提供 : 与各大医药公司的长期良好的合作关系
SYMIC

MGI has been value-added investor by bringing a diverse life science sector perspective, and has been strategically helpful and hands-on regarding business development in Japan. Ken Horne, co-founder & CEO

网站

正在开发一种新的治疗平台,专注于促进和加速创伤愈合

MGI为Symic Biomedical介绍相关领域的日本和全球性的医药公司以及医疗器械公司来探索联合研发的可能性

渕上 欣司,投资合伙人 我们提供 : 与各大医药公司的长期良好的合作关系以及医药领域的专业知识
高野 六月,投资经理 我们提供 : 丰富的客户开发,市场开拓以及商谈经验
© 2018 Mitsui & Co. Global Investment, Inc.